Status:
UNKNOWN
Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.
Lead Sponsor:
University of Turin, Italy
Conditions:
Covid19
C-reactive Protein
Eligibility:
All Genders
18+ years
Brief Summary
Although the recent literature is building a remarkable background to answer the many unknowns related to SARS-CoV-2 infection, it is absolutely necessary to finalize every clinical effort to collect ...
Eligibility Criteria
Inclusion
- hospitalized patients with clinical signs and symptoms of COVID-19, confirmed by nasopharyngeal swab RT-PCR of airways positive for SARS-CoV-2
- age \> 18 years
- Hospitalization in the departments of the hospitals involved
Exclusion
- none
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04873388
Start Date
March 1 2020
End Date
December 31 2024
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza di Torino
Torino, Italy, 10100